MedTrace Logo

Safety and Avoidance of Futile Excisions Through Skin Tele-triage

NCT05982600 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5

Last updated 2024-10-08

No results posted yet for this study

Summary

The goal of this study is to estimate the triage values, efficiency and safety of tele-dermoscopic triage of skin lesions suspected of melanoma. The main question\[s\] it aims to answer are:

* What is the rate of correct patient management by a single, 2, 3 and 5 dermatologists.
* What is the consequence for the patients if teledermoscopic triage is implemented, in termes of missed melanomas and reduced unnecessary excisions/biopsies.

Retrospectively included patients will have their skin lesions re-examined by setups of 1, 2, 3 and 5 tele-dermoscopists who will assign a tentative diagnosis and a recommended clinical action.

The investigators will compare the rate of correct patient management between the different setups.

Conditions

  • Melanoma (Skin)
  • Telemedicine

Interventions

DIAGNOSTIC_TEST

Single Assessor Teledermatological triage (TDT)

The skin lesion is assessed, diagnosed and triaged by one dermatologist assessors.

DIAGNOSTIC_TEST

2 people Teledermatological triage (TDT)

The skin lesion is assessed, diagnosed and triaged by 2 dermatologist assessors. Worst case overrules.

DIAGNOSTIC_TEST

3 people Teledermatological triage (TDT)

The skin lesion is assessed, diagnosed and triaged by 3 dermatologist assessors. Worst case and majority consensus assessments are calculated separately.

DIAGNOSTIC_TEST

5 people Teledermatological triage (TDT)

The skin lesion is assessed, diagnosed and triaged by 5 dermatologist assessors. Worst case and majority consensus assessments are calculated separately.

Sponsors & Collaborators

  • Herlev Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-09-01
Primary Completion
2023-12-31
Completion
2024-04-24

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05982600 on ClinicalTrials.gov